Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abe

Showing results (501-510 of 47,125) with videos related to

Pageof 4,713
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 11, 2012
[Pharmacological properties and clinical efficacy of pentetate calcium trisodium and pentetate zinc trisodium, antidotes for transuranium elements]Tsutomu Abe
International Journal of Hematology|October 14, 2011
Guest editorial: understanding the pathogenesis and the evolving treatment paradigm for multiple myeloma in the era of novel agentsMasahiro Abe
International Journal of Hematology|October 19, 2011
Targeting the interplay between myeloma cells and the bone marrow microenvironment in myelomaMasahiro Abe
Clinical Calcium|August 5, 2011
[Myeloma bone disease and RANKL signaling]Masahiro Abe
The Science of the Total Environment|April 21, 1999
Distribution of 1,4-dioxane in relation to possible sources in the water environmentA Abe
Physical Review. B, Condensed Matter|June 15, 1994
Optical-absorption spectra in fullerenes C60 and C70: Effects of Coulomb interactions, lattice fluctuations, and anisotropyHarigaya, Abe
Scientific American|July 17, 2024
Boom Times: The new costs-and long shadow-of living in a nuclear nationAbe Streep
Kekkaku : [Tuberculosis]|December 29, 1998
[Multidrug-resistant tuberculosis. 1. Drug susceptibility testing and its standardization]C Abe
Recent Patents on CNS Drug Discovery|January 29, 2008
Zolpidem therapy for movement disordersKazuo Abe
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|June 1, 1976
Secondary red cell pyruvate kinase deficiency. I. Study of 30 subjects of malignant hematological disordersS Abe
Pageof 4,713

Showing results (501-510 of 47,125) with videos related to

Sort By:
Pageof 4,713
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 11, 2012
[Pharmacological properties and clinical efficacy of pentetate calcium trisodium and pentetate zinc trisodium, antidotes for transuranium elements]Tsutomu Abe
International Journal of Hematology|October 14, 2011
Guest editorial: understanding the pathogenesis and the evolving treatment paradigm for multiple myeloma in the era of novel agentsMasahiro Abe
International Journal of Hematology|October 19, 2011
Targeting the interplay between myeloma cells and the bone marrow microenvironment in myelomaMasahiro Abe
Clinical Calcium|August 5, 2011
[Myeloma bone disease and RANKL signaling]Masahiro Abe
The Science of the Total Environment|April 21, 1999
Distribution of 1,4-dioxane in relation to possible sources in the water environmentA Abe
Physical Review. B, Condensed Matter|June 15, 1994
Optical-absorption spectra in fullerenes C60 and C70: Effects of Coulomb interactions, lattice fluctuations, and anisotropyHarigaya, Abe
Scientific American|July 17, 2024
Boom Times: The new costs-and long shadow-of living in a nuclear nationAbe Streep
Kekkaku : [Tuberculosis]|December 29, 1998
[Multidrug-resistant tuberculosis. 1. Drug susceptibility testing and its standardization]C Abe
Recent Patents on CNS Drug Discovery|January 29, 2008
Zolpidem therapy for movement disordersKazuo Abe
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|June 1, 1976
Secondary red cell pyruvate kinase deficiency. I. Study of 30 subjects of malignant hematological disordersS Abe
Pageof 4,713